Last update 29 Mar 2025

NI-0801

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
ALPHA-IP-10, EB-06, NI 0801
+ [1]
Target
Action
antagonists
Mechanism
CXCL10 antagonists(C-X-C motif chemokine ligand 10 antagonists)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
VitiligoPhase 2
Canada
01 Feb 2023
Liver Cirrhosis, BiliaryPhase 2
Switzerland
30 Jan 2022
Liver Cirrhosis, BiliaryPhase 2
Switzerland
30 Jan 2022
Primary Biliary CholangitisPhase 2
Italy
08 Sep 2011
Primary Biliary CholangitisPhase 2
United Kingdom
08 Sep 2011
Dermatitis, Allergic ContactPhase 1-19 Nov 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
29
fulejhhqno(abckzwvfys) = headaches (52%), pruritus (34%), fatigue (24%), and diarrhea (21%) krbmzsdcju (jwpmdbtnmh )
Negative
23 Mar 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free